PSY72 – Orphan Drug Pricing In France: Influence of Main Factors
Grand, H.; Samson, Anne-Laure; Aulois-Griot, M. (2014), PSY72 – Orphan Drug Pricing In France: Influence of Main Factors, Value in Health, 17, 7, p. A534. 10.1016/j.jval.2014.08.1702
TypeArticle accepté pour publication ou publié
Journal nameValue in Health
MetadataShow full item record
Abstract (EN)Orphan drugs (OD) require considerable expenditures, which causes difficulties in their market access. For several years, the price of these new therapies has often been criticized and considered as too high. However few studies about OD pricing mechanisms are available. The aim of the paper is to highlight the main factors that influence OD pricing in France.
Subjects / KeywordsDrugs; Health expenditures
Showing items related by title and author.
Fair Cost-Benefit Evaluation of Health Care: a Case Study of Blood Pressure Lowering Drugs in France Dormont, Brigitte; Luchini, Stéphane; Samson, Anne-Laure; Schokkaert, Erik; Thébaut, Clémence; Van de Voorde, Carine (2012) Communication / Conférence
Using Equivalent Income Concept in Blood Pressure Lowering Drugs Assessment. How Include Inequality Aversion in Cost/Benefit Analysis? Samson, Anne-Laure; Thébaut, Clémence; Dormont, Brigitte; Fleurbaey, Marc; Luchini, Stéphane; Schokkaert, Erik; Van de Voorde, Carine (2014) Communication / Conférence